reviewed thirty-five phase 3 randomized clinical trials with over 20,000 patients and did not find an increased incidence in all-cause mortality, major adverse cardiovascular events and venous thromboembolism in patients on these medications compared to patients in placebo or active comparator groups
While subcutaneous injections are generally well tolerated, some patients experience mild to moderate localized reactions at the injection site
Using a compromised solution means unknown dosing and potential safety risks
A total of 127 papers were screened, of which 83 papers were deemed unrelated, 17 focused on children with syndromic/genetic GHD, 13 were non-English, one was an abstract and one was a case report
Scientists use GHK-Cu peptide to investigate cellular signaling pathways involved in tissue structure and renewal processes
The mechanism profile makes biological sense, the safety record appears favorable, and the practical results align with what the science would predict